In a previous study, 2-h infusion with VIP induced migraine attacks in patients with migraine at an induction rate of 71% [33], similar to results reported in a separate study after 20-min PACAP38 infusion [14], suggesting a potential yet much less pronounced role for VIP in migraine pathogenesis that remains to be explored in future studies. The gene discussed is VIP; the disease is migraine disorder.